Life Briefing: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality Strategic angle: The legal battle underscores the complicated questions surrounding how best to evaluate hospital safety. Editorial Staff Mar 13
Life Briefing: White House says it’s ‘done’ with vaccines. MAHA begs to differ Strategic angle: As Trump political advisers try to move on from vaccine policy debates, MAHA movement insiders push back, calling RFK Jr. supporters vital to GOP's success. Editorial Staff Mar 13
Life Briefing: Congressional Advisers Call to Rein in Medicare Advantage Spending Amid Industry Pressure Strategic angle: Lobbying groups supported by insurance companies have criticized the research and promoted their own. Editorial Staff Mar 12
Life Briefing: Cancer cells can ‘barf’ proteins onto their cell surface, creating new targets for immunotherapies Strategic angle: An unexpected discovery may bring scientists closer to a long-sought goal: finding an ideal immunotherapy target for solid tumors. Editorial Staff Mar 12
Life Briefing: The Impact of Gun Violence on Youth Mental Health and Well-Being Strategic angle: Exposure to gun violence can severely affect the mental health of children and adolescents. Editorial Staff Mar 12
Life Briefing: Child and Adolescent Firearm Deaths: National Trends and Variation by Demographics and States Strategic angle: This brief analyzes the latest youth mortality data from the CDC, revealing alarming trends in firearm-related deaths among children and adolescents. Editorial Staff Mar 12
Life Briefing: Status of State Medicaid Expansion Decisions Strategic angle: Explore the current status of state decisions on Medicaid expansion under the Affordable Care Act. Editorial Staff Mar 12
Life Briefing: FDA launches unified system for adverse event reports Strategic angle: BIO's Crowley warns U.S. risks losing lead, a familiar red flag with Aldeyra, and other biotech news from The Readout. Editorial Staff Mar 12
Life Briefing: Analysis of Medicare data shows who mental health providers treat over telehealth Strategic angle: A new analysis reveals that mental health specialists utilizing telehealth did not significantly increase their rural patient base. Editorial Staff Mar 12
Life Briefing: STAT+: Pharmalittle: We’re reading about telehealth prescribers, a Lilly push against compounding, and more Strategic angle: Medical groups affiliated with telehealth companies the FDA warned about marketing of compounded weight loss drugs may be under the microscope, too Editorial Staff Mar 12
Life Briefing: An NIH Whistleblower Warning Strategic angle: The doctors behind the telehealth GLP-1 boom, a men's health office moment, and other health news Editorial Staff Mar 12
Life Briefing: Officials Amplify Fluoride Concerns as Federal Review and State Restrictions Advance Strategic angle: The EPA's safety review of fluoride coincides with growing state-level bans on community water fluoridation. Editorial Staff Mar 12
Life Briefing: STAT+: Is Aldeyra Therapeutics waving red flags with consequences? Strategic angle: How often do drugmakers complain about short sellers in SEC filings? And does it do any good? Editorial Staff Mar 12
Life Briefing: FDA Targets Telehealth Marketing of GLP-1 Drugs Strategic angle: The FDA is scrutinizing telehealth marketing practices for GLP-1 drugs, raising questions about prescribing trends. Editorial Staff Mar 12
Life Briefing: Momentum builds for a federal office of men’s health focused on disease prevention Strategic angle: For advocates who have been pushing to create a federal office of men's health, this could finally be the moment. Editorial Staff Mar 12
Life Briefing: Key Facts About Medicare Drug Price Negotiation Strategic angle: The federal government negotiates prices for high-cost drugs under Medicare Part B and Part D. Editorial Staff Mar 11
Life Novo Nordisk is warned by the FDA for failing to report side effects It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices. Editorial Staff Mar 11
Life Briefing: This billionaire wants to make science better, especially for AI Strategic angle: In this edition of AI Prognosis: Seemay Chou and Becky Pferdehirt's bold vision for how Radial will change science for AI Editorial Staff Mar 11
Life Briefing: How Does Health Spending in the U.S. Compare to Other Countries? Strategic angle: This analysis examines how U.S. health spending compares to health spending in other high-income nations. Editorial Staff Mar 11
Life Briefing: Red states hit hardest by reduced NIH funding Strategic angle: Epstein's "great friend" returns to biotech, sex differences in suicide, and other health news from Morning Rounds Editorial Staff Mar 11